4//SEC Filing
Kinsella Kevin J 4
Accession 0001116679-07-002483
CIK 0001042420other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 9:09 PM ET
Size
12.3 KB
Accession
0001116679-07-002483
Insider Transaction Report
Form 4
AKESIS PHARMACEUTICALS, INC.AKES.OB
Kinsella Kevin J
Director10% Owner
Transactions
- Purchase
Common Stock
2007-09-13$0.67/sh+2,500$1,675→ 8,131,775 total(indirect: By Partnership) - Purchase
Common Stock
2007-09-12$0.55/sh+5,000$2,750→ 8,131,775 total(indirect: By Partnership) - Purchase
Common Stock
2007-09-13$0.65/sh+5,000$3,250→ 8,131,775 total(indirect: By Partnership)
Footnotes (2)
- [F1]Includes: (A) 5,297,500 shares of Common Stock (including the 22,500 shares of Common Stock acquired in connection with the reported transactions) held of record by Avalon Ventures VII, L.P. (see note 2 below); and (B) 2,834,275 shares of Common Stock held by Mr. Kinsella in a trust for which Mr. Kinsella is the trustee.
- [F2]All of the shares of Common Stock acquired in connection with the reported transactions were acquired of record by Avalon Ventures VII, L.P. Mr. Kinsella is the managing member of Avalon Ventures VII GP, LLC, which acts as the general partner of Avalon Ventures VII, L.P. As a result, Mr. Kinsella may be deemed to be the beneficial owner of the shares of Common Stock acquired in connection with the reported transactions. However, Mr. Kinsella disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
AKESIS PHARMACEUTICALS, INC.
CIK 0001042420
Entity typeother
Related Parties
1- filerCIK 0001311643
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 9:09 PM ET
- Size
- 12.3 KB